Literature DB >> 21131380

The use of propranolol in the treatment of periocular infantile haemangiomas: a review.

I Claerhout1, M Buijsrogge, P Delbeke, S Walraedt, S De Schepper, B De Moerloose, K De Groote, C Decock.   

Abstract

Infantile haemangiomas (IH) are benign vascular tumours characterised by their very rapid growth. Although usually innocuous, periocular IH can cause serious visual loss through induction of strabismic, deprivational or anisometropic astigmatism. Common treatment modalities for these IH include intralesional and systemic oral steroids; however, both treatments are associated with potentially severe side effects. A report was published recently demonstrating the impressive effect of propranolol in the treatment of IH. This exciting finding has provoked a paradigm shift in the management of this condition. So far little has been reported in the specific ophthalmologic literature, although case reports are emerging. This review gives an overview of the recent findings and includes the authors' experience with 10 patients treated with propranol.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131380     DOI: 10.1136/bjo.2010.192245

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration.

Authors:  Jinsong Hao; Michael B Yang; Hongzhuo Liu; S Kevin Li
Journal:  J Ocul Pharmacol Ther       Date:  2011-08-02       Impact factor: 2.671

2.  Beta Blockers in the Treatment of Periocular Infantile Hemangiomas: A Review.

Authors:  Ann Q Tran; Catherine J Choi; Sara T Wester
Journal:  Intern Med Rev (Wash D C)       Date:  2016-10

3.  Beta-blockers for the treatment of problematic hemangiomas.

Authors:  Vishal K Sharma; Frankie Og Fraulin; Danielle O Dumestre; Lori Walker; A Robertson Harrop
Journal:  Can J Plast Surg       Date:  2013

Review 4.  Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.

Authors:  Beth A Drolet; Peter C Frommelt; Sarah L Chamlin; Anita Haggstrom; Nancy M Bauman; Yvonne E Chiu; Robert H Chun; Maria C Garzon; Kristen E Holland; Leonardo Liberman; Susan MacLellan-Tobert; Anthony J Mancini; Denise Metry; Katherine B Puttgen; Marcia Seefeldt; Robert Sidbury; Kendra M Ward; Francine Blei; Eulalia Baselga; Laura Cassidy; David H Darrow; Shawna Joachim; Eun-Kyung M Kwon; Kari Martin; Jonathan Perkins; Dawn H Siegel; Robert J Boucek; Ilona J Frieden
Journal:  Pediatrics       Date:  2012-12-24       Impact factor: 7.124

5.  Excellent response of infantile orofacio-orbital hemangioma to propranolol-pictorial depiction and literature review.

Authors:  Jonathan Theodore Gondi; Suhasini Gazula; A Rajasekhar; G Usharani
Journal:  Contemp Clin Dent       Date:  2016 Apr-Jun

6.  To compare intralesional and oral propranolol for treating periorbital and eyelid capillary hemangiomas.

Authors:  Aditi Mehta; Mandeep S Bajaj; Neelam Pushker; Bhavna Chawla; Amar Pujari; Sartaj S Grewal; Satinder Pal Singh Grewal; Simar Rajan Singh; Alisha Kishore; Neha Singh Yadav
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.